Humana Inc. (NYSE:HUM) Shares Sold by DnB Asset Management AS

DnB Asset Management AS cut its position in Humana Inc. (NYSE:HUM - Free Report) by 12.4% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 175,473 shares of the insurance provider's stock after selling 24,768 shares during the period. DnB Asset Management AS owned 0.15% of Humana worth $44,519,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds and other institutional investors have also modified their holdings of the company. Dynamic Technology Lab Private Ltd acquired a new stake in Humana in the third quarter valued at $404,000. Independent Advisor Alliance raised its position in shares of Humana by 68.3% during the 3rd quarter. Independent Advisor Alliance now owns 2,141 shares of the insurance provider's stock worth $678,000 after acquiring an additional 869 shares in the last quarter. Bank of Montreal Can lifted its stake in Humana by 18.4% during the third quarter. Bank of Montreal Can now owns 189,168 shares of the insurance provider's stock worth $60,452,000 after purchasing an additional 29,460 shares during the last quarter. FMR LLC boosted its holdings in Humana by 23.4% in the third quarter. FMR LLC now owns 3,388,859 shares of the insurance provider's stock valued at $1,073,387,000 after purchasing an additional 643,291 shares in the last quarter. Finally, Avestar Capital LLC increased its stake in Humana by 34.8% in the third quarter. Avestar Capital LLC now owns 1,372 shares of the insurance provider's stock valued at $435,000 after purchasing an additional 354 shares during the last quarter. 92.38% of the stock is currently owned by institutional investors and hedge funds.

Remove Ads

Analysts Set New Price Targets

Several analysts have recently weighed in on HUM shares. Morgan Stanley reduced their price objective on shares of Humana from $301.00 to $285.00 and set an "equal weight" rating for the company in a research report on Wednesday, February 12th. Cantor Fitzgerald restated a "neutral" rating and issued a $290.00 price objective on shares of Humana in a research note on Wednesday, February 12th. Piper Sandler raised their price objective on Humana from $270.00 to $288.00 and gave the stock a "neutral" rating in a report on Wednesday, January 15th. JPMorgan Chase & Co. reduced their target price on Humana from $257.00 to $256.00 and set a "neutral" rating for the company in a report on Tuesday, February 18th. Finally, Royal Bank of Canada restated an "outperform" rating and set a $283.00 price target on shares of Humana in a research note on Wednesday, February 12th. Eighteen analysts have rated the stock with a hold rating and five have issued a buy rating to the company's stock. According to data from MarketBeat.com, the stock has an average rating of "Hold" and an average price target of $285.68.

Humana Stock Performance

NYSE:HUM traded up $0.96 during mid-day trading on Tuesday, reaching $265.56. The stock had a trading volume of 278,885 shares, compared to its average volume of 1,750,822. Humana Inc. has a twelve month low of $213.31 and a twelve month high of $406.46. The business has a 50 day simple moving average of $269.77 and a 200 day simple moving average of $273.07. The firm has a market capitalization of $32.05 billion, a price-to-earnings ratio of 26.68, a PEG ratio of 2.05 and a beta of 0.57. The company has a debt-to-equity ratio of 0.68, a quick ratio of 1.76 and a current ratio of 1.76.

Humana (NYSE:HUM - Get Free Report) last posted its quarterly earnings results on Tuesday, February 11th. The insurance provider reported ($2.16) EPS for the quarter, beating the consensus estimate of ($2.26) by $0.10. Humana had a return on equity of 11.70% and a net margin of 1.02%. On average, analysts expect that Humana Inc. will post 16.47 earnings per share for the current fiscal year.

Humana Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, April 25th. Stockholders of record on Friday, March 28th will be paid a dividend of $0.885 per share. The ex-dividend date of this dividend is Friday, March 28th. This represents a $3.54 dividend on an annualized basis and a dividend yield of 1.33%. Humana's dividend payout ratio (DPR) is presently 35.58%.

Humana Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.